Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Cashman Neil, holds the title of Chief Scientific Officer at ProMIS Neurosciences Inc..
On 2026-11-02, the insider transacted 10,000 shares.The shares were transacted at a weighted average price of $3.86 per share, resulting in a total market-relevant value of $39K.
Cashman Neil (Chief Scientific Officer) bought $39K of $PMN
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.